Skip to Main Content
Table 5

Carcinogenic and non-carcinogenic risk assessment of study area

Non-carcinogenic risk
Carcinogenic risk
AsADDiADDdHiHQdHQTCRiTCRdTCR
Min 3.00 1*10−4 7.57*10−11 0.33 6.16*10−15 0.33 1.5*10−4 2.77*10−10 1.5*10−4 
Mean 8.38 2.79*10−4 2.11*10−10 0.93 1.72*10−14 0.93 4.18*10−4 7.74*10−10 4.19*10−4 
Median 7.52 2.50*10−4 1.90*10−10 0.83 1.54*10−14 0.83 3.75*10−4 6.95*10−10 3.75*10−4 
Max 25.00 8.33*10−4 6.31*10−10 2.77 5.13*10−14 2.77 1.24*10−3 2.31*10−9 1.25*10−3 
Non-carcinogenic risk
Carcinogenic risk
AsADDiADDdHiHQdHQTCRiTCRdTCR
Min 3.00 1*10−4 7.57*10−11 0.33 6.16*10−15 0.33 1.5*10−4 2.77*10−10 1.5*10−4 
Mean 8.38 2.79*10−4 2.11*10−10 0.93 1.72*10−14 0.93 4.18*10−4 7.74*10−10 4.19*10−4 
Median 7.52 2.50*10−4 1.90*10−10 0.83 1.54*10−14 0.83 3.75*10−4 6.95*10−10 3.75*10−4 
Max 25.00 8.33*10−4 6.31*10−10 2.77 5.13*10−14 2.77 1.24*10−3 2.31*10−9 1.25*10−3 

i, Ingestion; d, dermal, As (μg/L).

Close Modal

or Create an Account

Close Modal
Close Modal